Терапия протонами в детской нейроонкологии. Потенциальные достоинства и соотношение между стоимостью и результатами

Терапия протонами в детской нейроонкологии. Потенциальные достоинства и соотношение между стоимостью и результатами

Автор: Регентова О.С., Щербенко О.И., Кумирова Э.В., Антоненко Ф.Ф., Солодкий В.А.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Обзоры

Статья в выпуске: 2 т.23, 2024 года.

Бесплатный доступ

Цель исследования - проанализировать накопленный опыт и попытаться определить те клинические ситуации, в которых применение протонов окажется экономически и клинически более эффективным, чем фотонное излучение. Материал и методы. Проведен поиск и анализ доступных литературных источников, посвященных изучению оценки и сравнению эффективности протонного и фотонного пучка излучения в лечении опухолей центральной нервной системы, найденных в Medline, Embase и Кохрановской библиотеке, опубликованных за последние 25 лет.

Опухоли мозга, дети, ускоренные протоны, фотонное излучение, качество жизни, нейроонкология, лучевая терапия

Короткий адрес: https://sciup.org/140305914

IDR: 140305914   |   DOI: 10.21294/1814-4861-2024-23-2-92-100

Список литературы Терапия протонами в детской нейроонкологии. Потенциальные достоинства и соотношение между стоимостью и результатами

  • Zlokachestvennye novoobrazovaniya v Rossii v 2020 godu (zabolevaemost' i smertnost'). Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shakhzadovoi. M., 2021. 239 s.
  • Geyer J.R., Sposto R., Jennings M., Boyett J.M., Axtell R.A., Breiger D., Broxson E., Donahue B., Finlay J.L., Goldwein J.W., Heier L.A., Johnson D., Mazewski C., Miller D.C., Packer R., Puccetti D., Radcliffe J., Tao M.L., Shiminski-Maher T. Children’s Cancer Group. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol. 2005; 23(30): 7621-31. https://doi.org/10.1200/JCO.2005.09.095.
  • Oeffinger K.C., Mertens A.C., Sklar C.A., Kawashima T., Hudson M.M., Meadows A.T., Friedman D.L., Marina N., Hobbie W., Kadan-Lottick N.S., Schwartz C.L., Leisenring W., Robison L.L.; Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355(15): 1572-82. https://doi.org/10.1056/NEJMsa060185.
  • Armstrong G.T., Liu Q., Yasui Y., Neglia J.P., Leisenring W., Robison L.L., Mertens A.C. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27(14): 2328-38. https://doi.org/10.1200/JCO.2008.21.1425.
  • Paganetti H., Niemierko A., Ancukiewicz M., Gerweck L.E., Goitein M., Loeffler J.S., Suit H.D. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002; 53(2):407-21. https://doi.org/10.1016/s0360-3016(02)02754-2.
  • Shcherbenko O.I. Uskorennye protony v lechenii opukholei TsNS u detei. Prakticheskaya onkologiya. 2017; 18(3): 298-306.
  • Zabelin M.V., Klimanov V.A., Galyautdinova Zh.Zh., Samoilov A.S., Lebedev A.O., Shelukhina E.V. Protonnaya luchevaya terapiya: vozmozhnosti klinicheskogo primeneniya i perspektivy issledovaniya. Issledovaniya i praktika v meditsine. 2018; 5(1): 82-95. https://doi.org/10.17709/2409-2231-2018-5-1-10.
  • Solodkii V.A., Izmailov T.R., Polushkin P.V. Sravnenie effektivnosti protonnoi i fotonnoi terapii u patsientov s gliomami golovnogo mozga. Sibirskii onkologicheskii zhurnal. 2021; 20(2):127-35. https://doi.org/10.21294/1814-4861-2021-20-2-127-135.
  • Gordon K.B., Smyk D.I., Gulidov I.A. Protonnaya terapiya v lechenii opukholei oblasti golovy i shei: sostoyanie problemy i perspektivy razvitiya (obzor). Sovremennye tekhnologii v meditsine. 2021; 13(4): 70-81.
  • Oshiro Y., Mizumoto M., Okumura T., Sugahara S., Fukushima T., Ishikawa H., Nakao T., Hashimoto T., Tsuboi K., Ohkawa H., Kaneko M., Sakurai H. Clinical results of proton beam therapy for advanced neuroblastoma. Radiat Oncol. 2013; 8: 142. https://doi.org/10.1186/1748-717X-8-142.
  • Oshiro Y., Sugahara S., Fukushima T., Okumura T., Nakao T., Mizumoto M., Hashimoto T., Tsuboi K., Kaneko M., Sakurai H. Pediatric nasopharyngeal carcinoma treated with proton beam therapy. Two case reports. Acta Oncol. 2011; 50(3): 470-3. https://doi.org/10.3109/0284186X.2010.509106.
  • MacDonald T.J., Arenson E.B., Ater J., Sposto R., Bevan H.E., Bruner J., Deutsch M., Kurczynski E., Luerssen T., McGuire-Cullen P., O’Brien R., Shah N., Steinbok P., Strain J., Thomson J., Holmes E., Vezina G., Yates A., Phillips P., Packer R. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children’s Cancer Group Study 9933. Cancer. 2005;104(12): 2862-71. https://doi.org/10.1002/cncr.21593.
  • Muroi A., Mizumoto M., Ishikawa E., Ihara S., Fukushima H., Tsurubuchi T., Sakurai H., Matsumura A. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma. Childs Nerv Syst. 2020;36(3): 507-12. https://doi.org/10.1007/s00381-019-04420-9.
  • Vern-Gross T.Z., Schreiber J.E., Broniscer A., Wu S., Xiong X., Merchant T.E. Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade glioma. Neuro Oncol. 2014; 16(12): 1652-60. https://doi.org/10.1093/neuonc/nou101.
  • Merchant T.E., Kun L.E., Wu S., Xiong X., Sanford R.A., Boop F.A. Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol. 2009; 27(22): 3598-604. https://doi.org/10.1200/JCO.2008.20.9494.
  • Hug E.B., Muenter M.W., Archambeau J.O., DeVries A., Liwnicz B., Loredo L.N., Grove R.I., Slater J.D. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol. 2002;178(1): 10-7. https://doi.org/10.1007/s00066-002-0874-2.
  • Greenberger B.A., Pulsifer M.B., Ebb D.H., MacDonald S.M., Jones R.M., Butler W.E., Huang M.S., Marcus K.J., Oberg J.A., Tarbell N.J., Yock T.I. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014; 89(5): 1060-8. https://doi.org/10.1016/j.ijrobp.2014.04.053.
  • Grill J., Sainte-Rose C., Jouvet A., Gentet J.C., Lejars O., Frappaz D., Doz F., Rialland X., Pichon F., Bertozzi A.I., Chastagner P., Couanet D., Habrand J.L., Raquin M.A., Le Deley M.C., Kalifa C.; French Society of Paediatric Oncology. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol. 2005; 6(8): 573-80. https://doi.org/10.1016/S1470-2045(05)70252-7.
  • Eaton B.R., Esiashvili N., Kim S., Patterson B., Weyman E.A., Thornton L.T., Mazewski C., MacDonald T.J., Ebb D., MacDonald S.M., Tarbell N.J., Yock T.I. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016; 18(6):881-7. https://doi.org/10.1093/neuonc/nov302.
  • Ruggi A., Melchionda F., Sardi I., Pavone R., Meneghello L., Kitanovski L., Zaletel L.Z., Farace P., Zucchelli M., Scagnet M., Toni F., Righetto R., Cianchetti M., Prete A., Greto D., Cammelli S., Morganti A.G., Rombi B. Toxicity and Clinical Results after Proton Therapy for Pediatric Medulloblastoma: A Multi-Centric Retrospective Study. Cancers (Basel). 2022; 14(11): 2747. https://doi.org/10.3390/cancers14112747.
  • Trybula S.J., Youngblood M.W., Kemeny H.R., Clark J.R., Karras C.L., Hartsell W.F., Tomita T. Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy. Front Oncol. 2021; 11. https://doi.org/10.3389/fonc.2021.760691.
  • Merchant T.E., Li C., Xiong X., Kun L.E., Boop F.A., Sanford R.A. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009; 10(3): 258-66. https://doi.org/10.1016/s1470-2045(08)70342-5.
  • Ares C., Albertini F., Frei-Welte M., Bolsi A., Grotzer M.A., Goitein G., Weber D.C. Pencil beam scanning proton therapy for pediatric intracranial ependymoma. J Neurooncol. 2016; 128(1): 137-45. https://doi.org/10.1007/s11060-016-2090-4.
  • MacDonald S.M., Safai S., Trofimov A., Wolfgang J., Fullerton B., Yeap B.Y., Bortfeld T., Tarbell N.J., Yock T. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008; 71(4): 979-86. https://doi.org/10.1016/j.ijrobp.2007.11.065.
  • Macdonald S.M., Sethi R., Lavally B., Yeap B.Y., Marcus K.J., Caruso P., Pulsifer M., Huang M., Ebb D., Tarbell N.J., Yock T.I. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013; 15(11): 1552-9. https://doi.org/10.1093/neuonc/not121.
  • Eaton B.R., Chowdhry V., Weaver K., Liu L., Ebb D., Mac-Donald S.M., Tarbell N.J., Yock T.I. Use of proton therapy for re-irradiation in pediatric intracranial ependymoma. Radiother Oncol. 2015; 116(2):301-8. https://doi.org/10.1016/j.radonc.2015.07.023.
  • Gunther J.R., Sato M., Chintagumpala M., Ketonen L., Jones J.Y., Allen P.K., Paulino A.C., Okcu M.F., Su J.M., Wein-berg J., Boehling N.S., Khatua S., Adesina A., Dauser R., Whitehead W.E., Mahajan A. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015; 93(1): 54-63. https://doi.org/10.1016/j.ijrobp.2015.05.018.
  • Calaminus G., Kortmann R., Worch J., Nicholson J.C., Alapetite C., Garrè M.L., Patte C., Ricardi U., Saran F., Frappaz D. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol. 2013; 15(6):788-96. https://doi.org/10.1093/neuonc/not019.
  • Acharya S., DeWees T., Shinohara E.T., Perkins S.M. Long-term outcomes and late effects for childhood and young adulthood intracranial germinomas. Neuro Oncol. 2015; 17(5): 741-6. https://doi.org/10.1093/neuonc/nou311.
  • Yang J.C., Terezakis S.A., Dunkel I.J., Gilheeney S.W., Wolden S.L. Intensity-Modulated Radiation Therapy With Dose Painting: A Brain-Sparing Technique for Intracranial Germ Cell Tumors. Pediatr Blood Cancer. 2016; 63(4): 646-51. https://doi.org/10.1002/pbc.25867.
  • Park J., Park Y., Lee S.U., Kim T., Choi Y.K., Kim J.Y. Differential dosimetric benefit of proton beam therapy over intensity modulated radio-therapy for a variety of targets in patients with intracranial germ cell tumors. Radiat Oncol. 2015; 10: 135. https://doi.org/10.1186/s13014-015-0441-5.
  • Minniti G., Saran F., Traish D., Soomal R., Sardell S., Gonsalves A., Ashley S., Warrington J., Burke K., Mosleh-Shirazi A., Brada M. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol. 2007; 82(1): 90-5. https://doi.org/10.1016/j.radonc.2006.11.005.
  • Klimo P., Venable G.T., Boop F.A., Merchant T.E. Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment. J Neurosurg Pediatr. 2015; 15(5): 499-505. https://doi.org/10.3171/2014.10.PEDS14384.
  • Bishop A.J., Greenfield B., Mahajan A., Paulino A.C., Okcu M.F., Allen P.K., Chintagumpala M., Kahalley L.S., McAleer M.F., McGovern S.L., Whitehead W.E., Grosshans D.R. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014; 90(2): 354-61. https://doi.org/10.1016/j.ijrobp.2014.05.051.
  • Merchant T.E., Hua C.H., Shukla H., Ying X., Nill S., Oelfke U. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer. 2008; 51(1): 110-7. https://doi.org/10.1002/pbc.21530.
  • Pearce M.S., Salotti J.A., Little M.P., McHugh K., Lee C., Kim K.P., Howe N.L., Ronckers C.M., Rajaraman P., Sir Craft A.W., Parker L., Berrington de González A. Radiation exposure from CT scans in child-hood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012; 380(9840): 499-505. https://doi.org/10.1016/S0140-6736(12)60815-0.
  • Fuss M., Hug E.B., Schaefer R.A., Nevinny-Stickel M., Miller D.W., Slater J.M., Slater J.D. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys. 1999; 45(5):1117-26. https://doi.org/10.1016/s0360-3016(99)00337-5.
  • Pulsifer M.B., Sethi R.V., Kuhlthau K.A., MacDonald S.M., Tarbell N.J., Yock T.I. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors. Int J Radiat Oncol Biol Phys. 2015; 93(2): 400-7. https://doi.org/10.1016/j.ijrobp.2015.06.012.
  • Yahya N., Manan H.A. Neurocognitive impairment following proton therapy for paediatric brain tumour: a systematic review of post-therapy assessments. Support Care Cancer. 2021; 29(6): 3035-47. https://doi.org/10.1007/s00520-020-05808-z.
  • Mizumoto M., Murayama S., Akimoto T., Demizu Y., Fukushima T., Ishida Y., Oshiro Y., Numajiri H., Fuji H., Okumura T., Shirato H., Sakurai H. Long-term follow-up after proton beam therapy for pediatric tumors: a Japanese national survey. Cancer Sci. 2017; 108(3):444-7. https://doi.org/10.1111/cas.13140.
  • Jimenez R.B., Ahmed S., Johnson A., Thomas T., Depauw N., Horick N., Tansky J., Casey L., Evans C.L., Pulsifer M., Ebb D., Butler W.E., Fullerton B., Nancy J., Tarbell N.J., Torunn I., Yock T.I., MacDonald S.M. Proton Radiation Therapy for Pediatric Craniopharyngioma Int J Radiat Oncol Biol Phys . 2021; 110(5): 1480-7. https://doi.org/10.1016/j.ijrobp.2021.02.045.
  • Verma V., Mishra M.V., Mehta M.P. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. 2016;122(10): 1483-501. https://doi.org/10.1002/cncr.29882.
  • Mailhot Vega R.B., Kim J., Bussière M., Hattangadi J., HollanderA., Michalski J., Tarbell N.J., Yock T., MacDonald S.M. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer. 2013; 119(24): 4299-307. https://doi.org/10.1002/cncr.28322.
  • Ontario Health (Quality). Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021; 21(1): 1-142.
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp